These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1745688)

  • 21. Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin.
    Rojas-Ramirez JA; Crawley JN; Mendelson WB
    Neuropeptides; 1982 Dec; 3(2):129-38. PubMed ID: 7162563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of cholecystokinin on food intake in gonadectomized and intact rats: the influence of sex hormones.
    Wager-Srdar SA; Gannon M; Levine AS
    Physiol Behav; 1987; 40(1):25-8. PubMed ID: 3615652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats.
    Kuntz E; Pinget M; Damgé P
    JOP; 2004 Nov; 5(6):464-75. PubMed ID: 15536283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous cholecystokinin does not decrease food intake or gastric emptying in fasted rats.
    Smith GP; Greenberg D; Falasco JD; Avilion AA; Gibbs J; Liddle RA; Williams JA
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1462-6. PubMed ID: 2604005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic intraventricular administration of cholecystokinin octapeptide (CCK-8) suppresses feeding in rats.
    Schick RR; Stevens CW; Yaksh TL; Go VL
    Brain Res; 1988 May; 448(2):294-8. PubMed ID: 3378151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
    Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
    Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):573-83. PubMed ID: 2577226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraperitoneal cholecystokinin-8 induces atypical somnolence and EEG changes.
    Depoortere H; De Saint-Hilaire Z; Nicolaïdis S
    Physiol Behav; 1990 Dec; 48(6):873-7. PubMed ID: 2087520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central insulin enhances sensitivity to cholecystokinin.
    Riedy CA; Chavez M; Figlewicz DP; Woods SC
    Physiol Behav; 1995 Oct; 58(4):755-60. PubMed ID: 8559787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoglycemia activates arousal-related neurons and increases wake time in adult rats.
    Tkacs NC; Pan Y; Sawhney G; Mann GL; Morrison AR
    Physiol Behav; 2007 Jun; 91(2-3):240-9. PubMed ID: 17434543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of feeding by the C-terminal tetrapeptide fragment of cholecystokinin in a novel environment.
    Kádár T; Penke B; Kovács K; Telegdy G
    Neuropeptides; 1986; 7(2):97-108. PubMed ID: 3703184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.
    Reidelberger RD; O'Rourke MF
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1512-8. PubMed ID: 2481407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.
    Barrachina MD; Martínez V; Wang L; Wei JY; Taché Y
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10455-60. PubMed ID: 9294232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal infusion of a liquid diet alters CCK and NPY concentrations in specific brain areas of rats.
    Della-Fera MA; Koch J; Gingerich RL; Baile CA
    Physiol Behav; 1990 Sep; 48(3):423-8. PubMed ID: 2267251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of exocrine pancreatic insufficiency in streptozotocin-induced type 1 diabetes mellitus.
    Patel R; Shervington A; Pariente JA; Martinez-Burgos MA; Salido GM; Adeghate E; Singh J
    Ann N Y Acad Sci; 2006 Nov; 1084():71-88. PubMed ID: 17151294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
    Ebenezer IS; Baldwin BA
    Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of seasonality in growth hormone-transgenic coho salmon (Oncorhynchus kisutch) and the role of cholecystokinin in seasonal feeding behavior.
    Lõhmus M; Raven PA; Sundström LF; Devlin RH
    Horm Behav; 2008 Sep; 54(4):506-13. PubMed ID: 18667200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.